Asia-Pacific markets mixed following losses on Wall Street; Bank of Japan meeting in focus

Asia-Pacific markets mixed following losses on Wall Street; Bank of Japan meeting in focus


© Marco Bottigelli | Moment | Getty Images

Asia-Pacific markets traded mixed on Wednesday, following declines on Wall Street after a sell-off in technology stocks picked up pace.

Japanese markets will be in focus for investors, with the Bank of Japan poised to announce its monetary policy decision later in the day. The central bank is widely expected to hold interest rates steady at 0.5%.

Japan’s benchmark Nikkei 225 edged up 0.41% shortly after the open, while the broader Topix index increased 0.70%.

Over in South Korea, the Kospi index started the day 0.91% higher, while the small-cap Kosdaq fell 0.27% in choppy trade.

Australia’s S&P/ASX 200 pared losses to trade 0.13% lower.

Futures for Hong Kong’s Hang Seng index stood at 24,716, pointing to a slightly weaker open compared to the HSI’s close of 24,740.57.

Overnight in the U.S., stocks were back in the red after two straight winning sessions.

The Dow Jones Industrial Average lost 260.32 points, or 0.62%, closing at 41,581.31. The S&P 500 shed 1.07%, ending at 5,614.66. The broad market index concluded the day 8.6% off its closing high reached in February, bringing it near correction territory. The Nasdaq Composite dropped 1.71% and settled at 17,504.12.

Tesla, one of the stocks hardest hit during the market’s recent correction, was down yet again on Tuesday. The stock fell more than 5% after RBC Capital Markets lowered its price target on the electric vehicle name, given stiff competition in the EV space.

Elsewhere, shares of Palantir and Nvidia dropped nearly 4% and more than 3%, respectively. The Technology Select Sector SPDR Fund (XLK) was also down more than 1%.

— CNBC’s Sean Conlon and Alex Harring contributed to this report.



Source

Nine of the largest pharma companies ink deals with Trump to lower drug prices
World

Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]

Read More
Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees
World

Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees

Sundar Pichai, chief executive officer of Alphabet Inc., during the Bloomberg Tech conference in San Francisco, California, US, on Wednesday, June 4, 2025. David Paul Morris | Bloomberg | Getty Images With the AI talent wars heating up between companies like OpenAI, Meta and Anthropic, one way Google has been competing is by aggressively rehiring […]

Read More
Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
World

Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt

Chris Ratcliffe | Bloomberg | Getty Images Tween retailer Claire’s is facing legal challenges from some of its Asia-based suppliers over millions in unpaid debts as it tries to emerge from a second bankruptcy under new ownership, according to claims the suppliers filed in Hong Kong.  The clash with vendors comes as private equity firm […]

Read More